Mónica
Martínez Fernández
Publications (45) Mónica Martínez Fernández publications
2023
-
Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study
Cancer Medicine, Vol. 12, Núm. 6, pp. 6615-6622
2022
-
BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up
European Urology
-
Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC
Cancers, Vol. 14, Núm. 11
2021
-
Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture
Nature Communications, Vol. 12, Núm. 1
-
Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers
Clinical and Experimental Metastasis, Vol. 38, Núm. 2, pp. 239-251
2020
2019
-
CDK4/6 inhibitor as a novel therapeutic approach for advanced bladder cancer independently of RB1 status
Clinical Cancer Research, Vol. 25, Núm. 1, pp. 390-402
-
CTCs expression profiling for advanced breast cancer monitoring
Cancers, Vol. 11, Núm. 12
-
Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
Frontiers in Genetics, Vol. 10
-
Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status
Scientific Reports, Vol. 9, Núm. 1
-
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
Nature Medicine
2018
-
The Ras-related gene ERAS is involved in human and murine breast cancer
Scientific Reports, Vol. 8, Núm. 1
-
Thyroid Hormone Receptors Regulate the Expression of microRNAs with Key Roles in Skin Homeostasis
Thyroid, Vol. 28, Núm. 7, pp. 921-932
2017
-
BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer
Clinical Cancer Research, Vol. 23, Núm. 23, pp. 7388-7399
-
Correction: Deregulation of the pRb-E2F4 axis alters epidermal homeostasis and favors tumor development [Oncotarget, 7, (2016) (75712-75728)] DOI: 10.18632/oncotarget.12362
Oncotarget
-
Epigenetic mutations and cancer therapy Effectiven(EZH2)
Translational Cancer Research
-
Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma
Oncotarget, Vol. 8, Núm. 18, pp. 30410-30421
-
Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer
Oncotarget, Vol. 8, Núm. 6, pp. 10531-10542
-
UroMark—a urinary biomarker assay for the detection of bladder cancer
Clinical Epigenetics, Vol. 9, Núm. 1